Overview
Dr. Claire Henchcliffe is a board-certified UCI Health neurologist who specializes in the diagnosis and treatment of movement disorders. She has more than 20 years of experience treating patients with Parkinson’s disease and related conditions.She earned her medical degree at the College of Physicians and Surgeons of Columbia University in New York City. She completed an internal medicine internship and neurology residency at New York Presbyterian Hospital/Columbia University Medical Center, followed by a movement disorders fellowship at Columbia University Medical Center.She previously earned a doctorate in philosophy from the University of Oxford in the United Kingdom and completed a postdoctoral fellowship in genetics at the University of Cambridge and UC Berkeley.Prior to becoming chair of the UCI School of Medicine's Department of Neurology, Henchcliffe served as Weill Cornell Medicine's vice-chair for clinical neurology research and chief of neurodegenerative disorders, and as the attending neurologist at New York Presbyterian Hospital, both in New York City.An internationally recognized clinician and scientist in neurological disorders, Henchcliffe's research is focused on developing new treatments for Parkinson’s disease, including stem cell-based regenerative therapy and gene therapy. At Weill Cornell Medicine, she led a clinical trials network team as part of the National Institute of Neurological Disorders and Stroke (NINDS) initiative to improve treatment for neurological diseases in partnership with academia, private foundations and industry.She has published in many peer-reviewed journals and has made presentations at national and international conferences on Parkinson’s disease and, most recently, on stem-cell therapies and biomarker development.
Dr. Henchcliffe is highly rated in 2 conditions, according to our data. Her clinical expertise encompasses Parkinson's Disease, Movement Disorders, Drug Induced Dyskinesia, and Primary Lateral Sclerosis.
Dr. Henchcliffe is board certified in American Board Of Psychiatry And Neurology - Neurology. She is actively involved in clinical research, co-authoring 56 peer reviewed articles.
Graduate Institution
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- INSURANCE PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE
- PPO
- EPO
- HMO
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
856 Health Sciences Road, Suite 2600, Irvine, CA 92617
101 The City Drive South, Orange, CA 92868
Additional Areas of Focus
Dr. Henchcliffe has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
UCI Health - Irvine Chao Family Comprehensive Cancer Center & Ambulatory Care
Dr. Daniela A. Bota is a UCI Health neuro-oncologist who specializes in the treatment of primary and metastatic brain and spinal cord tumors, as well as in the neurological complications of cancers.She earned her medical degree at Carol Davila University of Medicine and Pharmacy in Bucharest, Romania. She completed a residency in neurology at University of Kansas Medical Center in Kansas City, followed by a fellowship in neuro-oncology at Duke University School of Medicine in Durham, N.C.Bota's academic research and clinical practice focus on innovative treatments for brain malignancies. She currently serves as a principal investigator for numerous studies including novel glioblastoma stem-cell targeted chemotherapy agents, cellular immunotherapy studies and wearable devices. She consults for multiple companies involved in developing drugs, cellular therapies and devices for human use. In support of these efforts, Bota’s translational research lab investigates potential therapies for malignant gliomas.She also serves as vice dean for Clinical Research at theUCI School of Medicineand director of theUCI Alpha Stem Cell Clinic. Dr. Bota is highly rated in 24 conditions, according to our data. Her clinical expertise encompasses Glioblastoma, Astrocytoma, Glioma, and Brain Tumor.
UCI Health ALS & Neuromuscular Center
Dr. Tahseen Mozaffar is a Professor of Neurology, Orthopaedic Surgery and Pathology and Laboratory Medicine at University of California, Irvine. He is the Director of the UC Irvine-MDA ALS and Neuromuscular Center and the Director of the Division of Neuromuscular Diseases. Dr. Mozaffar serves as chair of one of the biomedical committees and the institutional liaison for Trials Innovation Hub for the Center for Translational Sciences Award (CTSA) at University of California, Irvine. He is the Principal Investigator for UCI-NEXT, the NeuroNEXT award to the University of California, Irvine, one of 25 such NeuroNEXT sites funded by the NINDS/NIH.. Dr. Mozaffar is highly rated in 32 conditions, according to our data. His clinical expertise encompasses Pompe Disease, Inclusion Body Myositis, Myositis, Limb-Girdle Muscular Dystrophy, and Thymectomy. Dr. Mozaffar is board certified in Board Certification In Neurology, 1996-2026, Board Certification In Neuromuscular Medicine, 2008-2028, and Board Certification In Clinical Neuromuscular Pathology, 2015 - 2025. Dr. Mozaffar is currently accepting new patients.
UCI Health ALS & Neuromuscular Center
Dr. Namita Goyal is a UCI Health neurologist with board certifications in neurology, electrodiagnostic medicine and neuromuscular medicine. Dr. Goyal is highly rated in 19 conditions, according to our data. Her clinical expertise encompasses Inclusion Body Myositis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Myositis, and Primary Lateral Sclerosis. Dr. Goyal is board certified in CA State Medical License 2012 - 2024 and MA State Medical License 2006 - 2023.
Frequently Asked Questions about Dr. Claire Henchcliffe
How do I make an appointment with Dr. Claire Henchcliffe?
You can book an appointment with Dr. Claire Henchcliffe by calling their office at 714-456-7720. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Claire Henchcliffe a top-rated expert for Parkinson's Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Claire Henchcliffe is classified as an Elite expert for Parkinson's Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Claire Henchcliffe specialize in?
While Dr. Claire Henchcliffe is a Neurology, they have specific expertise in Parkinson's Disease, Movement Disorders, and Drug Induced Dyskinesia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.
Does Dr. Claire Henchcliffe participate in research or clinical trials?
Yes. Dr. Claire Henchcliffe has published 56 articles and abstracts on conditions like Parkinson's Disease. You can view a list of Dr. Claire Henchcliffe's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Claire Henchcliffe accept my insurance?
Dr. Claire Henchcliffe accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 714-456-7720 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Elite
- Parkinson's DiseaseDr. Henchcliffe isElite. Learn about Parkinson's Disease.
- Distinguished
- Movement DisordersDr. Henchcliffe isDistinguished. Learn about Movement Disorders.
- Experienced
- Alzheimer's DiseaseDr. Henchcliffe isExperienced. Learn about Alzheimer's Disease.
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- DementiaDr. Henchcliffe isExperienced. Learn about Dementia.
- Drug Induced DyskinesiaDr. Henchcliffe isExperienced. Learn about Drug Induced Dyskinesia.
- Primary Lateral SclerosisDr. Henchcliffe isExperienced. Learn about Primary Lateral Sclerosis.
- Tardive DyskinesiaDr. Henchcliffe isExperienced. Learn about Tardive Dyskinesia.